Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 3 studies | 26% ± 5% | |
ciliated cell | 3 studies | 20% ± 3% |
Insufficient scRNA-seq data for expression of FANCF at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 536.30 | 180 / 180 | 100% | 18.92 | 430 / 430 |
pancreas | 100% | 840.48 | 328 / 328 | 100% | 17.53 | 178 / 178 |
prostate | 100% | 594.63 | 245 / 245 | 100% | 23.53 | 502 / 502 |
kidney | 100% | 550.29 | 89 / 89 | 100% | 16.47 | 898 / 901 |
stomach | 99% | 566.53 | 357 / 359 | 100% | 22.34 | 286 / 286 |
thymus | 100% | 573.42 | 653 / 653 | 99% | 17.42 | 601 / 605 |
brain | 99% | 405.54 | 2622 / 2642 | 100% | 14.36 | 703 / 705 |
breast | 99% | 465.07 | 455 / 459 | 100% | 29.90 | 1115 / 1118 |
skin | 100% | 562.60 | 1807 / 1809 | 99% | 17.64 | 466 / 472 |
intestine | 99% | 567.54 | 958 / 966 | 99% | 23.85 | 522 / 527 |
bladder | 100% | 462.33 | 21 / 21 | 98% | 18.54 | 492 / 504 |
esophagus | 99% | 406.56 | 1425 / 1445 | 98% | 16.65 | 180 / 183 |
liver | 100% | 462.15 | 226 / 226 | 96% | 11.24 | 388 / 406 |
adrenal gland | 100% | 687.76 | 257 / 258 | 94% | 11.36 | 217 / 230 |
lung | 94% | 371.18 | 544 / 578 | 99% | 18.20 | 1149 / 1155 |
uterus | 99% | 533.62 | 169 / 170 | 93% | 15.14 | 429 / 459 |
spleen | 100% | 931.48 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.51 | 1 / 1 |
adipose | 99% | 327.03 | 1188 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 323.52 | 1317 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 19.06 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.06 | 43 / 45 |
eye | 0% | 0 | 0 / 0 | 95% | 11.55 | 76 / 80 |
heart | 94% | 269.88 | 808 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 455.28 | 760 / 929 | 0% | 0 | 0 / 0 |
muscle | 51% | 77.31 | 406 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0036297 | Biological process | interstrand cross-link repair |
GO_0043240 | Cellular component | Fanconi anaemia nuclear complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | FANCF |
Protein name | Fanconi anemia, complementation group F (cDNA FLJ10854 fis, clone NT2RP4001507, highly similar to Fanconi anemia group F protein) Fanconi anemia group F protein (Protein FACF) |
Synonyms | hCG_1646608 |
Description | FUNCTION: DNA repair protein that may operate in a postreplication repair or a cell cycle checkpoint function. May be implicated in interstrand DNA cross-link repair and in the maintenance of normal chromosome stability (By similarity). . |
Accessions | ENST00000327470.6 Q9NPI8 A3KME0 |